.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
QuintilesIMS
Queensland Health
Baxter
Colorcon
Healthtrust
US Army
Harvard Business School
UBS
AstraZeneca

Generated: September 22, 2017

DrugPatentWatch Database Preview

Ortho Mcneil Company Profile

« Back to Dashboard

What is the competitive landscape for ORTHO MCNEIL, and what generic alternatives to ORTHO MCNEIL drugs are available?

ORTHO MCNEIL has thirty-eight approved drugs.

There are ten US patents protecting ORTHO MCNEIL drugs.

There are one hundred and fifty-eight patent family members on ORTHO MCNEIL drugs in thirty countries.

Summary for Applicant: Ortho Mcneil

Patents:10
Tradenames:42
Ingredients:22
NDAs:38
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm
TYLENOL W/ CODEINE
acetaminophen; codeine phosphate
TABLET;ORAL085056-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
PARAFLEX
chlorzoxazone
TABLET;ORAL011300-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-006Feb 2, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
CLISTIN
carbinoxamine maleate
TABLET;ORAL008915-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
TYLENOL W/ CODEINE
acetaminophen; codeine phosphate
TABLET;ORAL085056-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
ORTHO-NOVUM 1/35-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21017489-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Pharm
ORTHO-NOVUM 1/80 28
mestranol; norethindrone
TABLET;ORAL-28016715-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000DISCNNoNo► Subscribe► Subscribe ► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000DISCNNoNo► Subscribe► Subscribe ► Subscribe
Ortho Mcneil Pharm
ORTHO-NOVUM 7/14-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21019004-001Apr 4, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ortho Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ortho Mcneil Pharm
FLOXIN
ofloxacin
INJECTABLE;INJECTION020087-002Mar 31, 1992► Subscribe► Subscribe
Ortho Mcneil Janssen
VIADUR
leuprolide acetate
IMPLANT;IMPLANTATION021088-001Mar 3, 2000► Subscribe► Subscribe
Ortho Mcneil Pharm
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
ofloxacin
INJECTABLE;INJECTION020087-004Mar 31, 1992► Subscribe► Subscribe
Ortho Mcneil
HALDOL
haloperidol
TABLET;ORAL015921-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Ortho Mcneil

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,261,584 Sustained delivery of an active agent using an implantable system► Subscribe
8,298,562Sustained delivery of an active agent using an implantable system► Subscribe
8,080,259Sustained delivery of an active agent using an implantable system► Subscribe
7,655,257Sustained delivery of an active agent using an implantable system► Subscribe
6,635,268 Sustained delivery of an active agent using an implantable system► Subscribe
8,535,701Sustained delivery of an active agent using an implantable system► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ortho Mcneil Drugs

Country Document Number Estimated Expiration
European Patent Office1066081► Subscribe
Cyprus2487► Subscribe
Austria281153► Subscribe
Denmark1041975► Subscribe
Romania119929► Subscribe
Israel178824► Subscribe
Germany69723589► Subscribe
Germany69715639► Subscribe
Spain2215967► Subscribe
Taiwan575438► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Ortho Mcneil Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0001France► SubscribePRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
C0041Belgium► SubscribePRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
C0018France► SubscribePRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
2009004,C0770388Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
1214076/01Switzerland► SubscribePRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
0136011/03Switzerland► SubscribePRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417
C0008Belgium► SubscribePRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107
2009Austria► SubscribePRODUCT NAME: KOMBINATION AUS ESTRADIOLVALERAT UND DIENOGEST; NAT. REGISTRATION NO/DATE: 1-28003 20090203; FIRST REGISTRATION: BE BE 327792 20081103
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Harvard Business School
Merck
Chinese Patent Office
Farmers Insurance
Deloitte
Mallinckrodt
Chubb
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot